▶ 調査レポート

世界の三叉神経痛治療薬市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Trigeminal Neuralgia Therapeutics Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の三叉神経痛治療薬市場規模・現状・予測(2021年-2027年) / Global Trigeminal Neuralgia Therapeutics Market Size, Status and Forecast 2021-2027 / QYR2104Z5743資料のイメージです。• レポートコード:QYR2104Z5743
• 出版社/出版日:QYResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、91ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥546,000 (USD3,900)▷ お問い合わせ
  Multi User/Five User¥819,000 (USD5,850)▷ お問い合わせ
  Enterprise License(同一法人内共有可)¥1,092,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、三叉神経痛治療薬のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(ニューロリリースTN、オナボツリヌムトキシンA、オキシトシン、塩酸ラキサトリジン、U-2902、その他)、用途別市場規模(病院、診療所、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。
・市場概要
・三叉神経痛治療薬の市場動向
・企業の競争状況、市場シェア
・三叉神経痛治療薬の種類別市場規模(ニューロリリースTN、オナボツリヌムトキシンA、オキシトシン、塩酸ラキサトリジン、U-2902、その他)
・三叉神経痛治療薬の用途別市場規模(病院、診療所、その他)
・三叉神経痛治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・三叉神経痛治療薬のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等)
・三叉神経痛治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・三叉神経痛治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・三叉神経痛治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Allergan, Inc.、Biogen, Inc.、Kineta, Inc.、Merz Pharma GmbH & Co. KgaA、Trigemina, Inc.)
・結論

Market Analysis and Insights: Global Trigeminal Neuralgia Therapeutics Market
The global Trigeminal Neuralgia Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Trigeminal Neuralgia Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Trigeminal Neuralgia Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Trigeminal Neuralgia Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Trigeminal Neuralgia Therapeutics market.

Global Trigeminal Neuralgia Therapeutics Scope and Market Size
Trigeminal Neuralgia Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Trigeminal Neuralgia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
NeuroRelease TN
Onabotulinumtoxin A
Oxytocin
Raxatrigine Hydrochloride
U-2902
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Allergan, Inc.
Biogen, Inc.
Kineta, Inc.
Merz Pharma GmbH & Co. KgaA
Trigemina, Inc.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Trigeminal Neuralgia Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 NeuroRelease TN
1.2.3 Onabotulinumtoxin A
1.2.4 Oxytocin
1.2.5 Raxatrigine Hydrochloride
1.2.6 U-2902
1.2.7 Others
1.3 Market by Application
1.3.1 Global Trigeminal Neuralgia Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Trigeminal Neuralgia Therapeutics Market Perspective (2016-2027)
2.2 Trigeminal Neuralgia Therapeutics Growth Trends by Regions
2.2.1 Trigeminal Neuralgia Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Trigeminal Neuralgia Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Trigeminal Neuralgia Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Trigeminal Neuralgia Therapeutics Industry Dynamic
2.3.1 Trigeminal Neuralgia Therapeutics Market Trends
2.3.2 Trigeminal Neuralgia Therapeutics Market Drivers
2.3.3 Trigeminal Neuralgia Therapeutics Market Challenges
2.3.4 Trigeminal Neuralgia Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Trigeminal Neuralgia Therapeutics Players by Revenue
3.1.1 Global Top Trigeminal Neuralgia Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Trigeminal Neuralgia Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Trigeminal Neuralgia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Trigeminal Neuralgia Therapeutics Revenue
3.4 Global Trigeminal Neuralgia Therapeutics Market Concentration Ratio
3.4.1 Global Trigeminal Neuralgia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Trigeminal Neuralgia Therapeutics Revenue in 2020
3.5 Trigeminal Neuralgia Therapeutics Key Players Head office and Area Served
3.6 Key Players Trigeminal Neuralgia Therapeutics Product Solution and Service
3.7 Date of Enter into Trigeminal Neuralgia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Trigeminal Neuralgia Therapeutics Breakdown Data by Type
4.1 Global Trigeminal Neuralgia Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Trigeminal Neuralgia Therapeutics Forecasted Market Size by Type (2022-2027)

5 Trigeminal Neuralgia Therapeutics Breakdown Data by Application
5.1 Global Trigeminal Neuralgia Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Trigeminal Neuralgia Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Trigeminal Neuralgia Therapeutics Market Size (2016-2027)
6.2 North America Trigeminal Neuralgia Therapeutics Market Size by Type
6.2.1 North America Trigeminal Neuralgia Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Trigeminal Neuralgia Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Trigeminal Neuralgia Therapeutics Market Size by Type (2016-2027)
6.3 North America Trigeminal Neuralgia Therapeutics Market Size by Application
6.3.1 North America Trigeminal Neuralgia Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Trigeminal Neuralgia Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Trigeminal Neuralgia Therapeutics Market Size by Application (2016-2027)
6.4 North America Trigeminal Neuralgia Therapeutics Market Size by Country
6.4.1 North America Trigeminal Neuralgia Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Trigeminal Neuralgia Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Trigeminal Neuralgia Therapeutics Market Size (2016-2027)
7.2 Europe Trigeminal Neuralgia Therapeutics Market Size by Type
7.2.1 Europe Trigeminal Neuralgia Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Trigeminal Neuralgia Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Trigeminal Neuralgia Therapeutics Market Size by Type (2016-2027)
7.3 Europe Trigeminal Neuralgia Therapeutics Market Size by Application
7.3.1 Europe Trigeminal Neuralgia Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Trigeminal Neuralgia Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Trigeminal Neuralgia Therapeutics Market Size by Application (2016-2027)
7.4 Europe Trigeminal Neuralgia Therapeutics Market Size by Country
7.4.1 Europe Trigeminal Neuralgia Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Trigeminal Neuralgia Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Trigeminal Neuralgia Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Trigeminal Neuralgia Therapeutics Market Size by Type
8.2.1 Asia-Pacific Trigeminal Neuralgia Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Trigeminal Neuralgia Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Trigeminal Neuralgia Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Trigeminal Neuralgia Therapeutics Market Size by Application
8.3.1 Asia-Pacific Trigeminal Neuralgia Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Trigeminal Neuralgia Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Trigeminal Neuralgia Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Trigeminal Neuralgia Therapeutics Market Size by Region
8.4.1 Asia-Pacific Trigeminal Neuralgia Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Trigeminal Neuralgia Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Trigeminal Neuralgia Therapeutics Market Size (2016-2027)
9.2 Latin America Trigeminal Neuralgia Therapeutics Market Size by Type
9.2.1 Latin America Trigeminal Neuralgia Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Trigeminal Neuralgia Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Trigeminal Neuralgia Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Trigeminal Neuralgia Therapeutics Market Size by Application
9.3.1 Latin America Trigeminal Neuralgia Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Trigeminal Neuralgia Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Trigeminal Neuralgia Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Trigeminal Neuralgia Therapeutics Market Size by Country
9.4.1 Latin America Trigeminal Neuralgia Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Trigeminal Neuralgia Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Trigeminal Neuralgia Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Trigeminal Neuralgia Therapeutics Market Size by Type
10.2.1 Middle East & Africa Trigeminal Neuralgia Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Trigeminal Neuralgia Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Trigeminal Neuralgia Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Trigeminal Neuralgia Therapeutics Market Size by Application
10.3.1 Middle East & Africa Trigeminal Neuralgia Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Trigeminal Neuralgia Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Trigeminal Neuralgia Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Trigeminal Neuralgia Therapeutics Market Size by Country
10.4.1 Middle East & Africa Trigeminal Neuralgia Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Trigeminal Neuralgia Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Allergan, Inc.
11.1.1 Allergan, Inc. Company Details
11.1.2 Allergan, Inc. Business Overview
11.1.3 Allergan, Inc. Trigeminal Neuralgia Therapeutics Introduction
11.1.4 Allergan, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2016-2021)
11.1.5 Allergan, Inc. Recent Development
11.2 Biogen, Inc.
11.2.1 Biogen, Inc. Company Details
11.2.2 Biogen, Inc. Business Overview
11.2.3 Biogen, Inc. Trigeminal Neuralgia Therapeutics Introduction
11.2.4 Biogen, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2016-2021)
11.2.5 Biogen, Inc. Recent Development
11.3 Kineta, Inc.
11.3.1 Kineta, Inc. Company Details
11.3.2 Kineta, Inc. Business Overview
11.3.3 Kineta, Inc. Trigeminal Neuralgia Therapeutics Introduction
11.3.4 Kineta, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2016-2021)
11.3.5 Kineta, Inc. Recent Development
11.4 Merz Pharma GmbH & Co. KgaA
11.4.1 Merz Pharma GmbH & Co. KgaA Company Details
11.4.2 Merz Pharma GmbH & Co. KgaA Business Overview
11.4.3 Merz Pharma GmbH & Co. KgaA Trigeminal Neuralgia Therapeutics Introduction
11.4.4 Merz Pharma GmbH & Co. KgaA Revenue in Trigeminal Neuralgia Therapeutics Business (2016-2021)
11.4.5 Merz Pharma GmbH & Co. KgaA Recent Development
11.5 Trigemina, Inc.
11.5.1 Trigemina, Inc. Company Details
11.5.2 Trigemina, Inc. Business Overview
11.5.3 Trigemina, Inc. Trigeminal Neuralgia Therapeutics Introduction
11.5.4 Trigemina, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2016-2021)
11.5.5 Trigemina, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Trigeminal Neuralgia Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of NeuroRelease TN
Table 3. Key Players of Onabotulinumtoxin A
Table 4. Key Players of Oxytocin
Table 5. Key Players of Raxatrigine Hydrochloride
Table 6. Key Players of U-2902
Table 7. Key Players of Others
Table 8. Global Trigeminal Neuralgia Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Trigeminal Neuralgia Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Trigeminal Neuralgia Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Trigeminal Neuralgia Therapeutics Market Share by Regions (2016-2021)
Table 12. Global Trigeminal Neuralgia Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Trigeminal Neuralgia Therapeutics Market Share by Regions (2022-2027)
Table 14. Trigeminal Neuralgia Therapeutics Market Trends
Table 15. Trigeminal Neuralgia Therapeutics Market Drivers
Table 16. Trigeminal Neuralgia Therapeutics Market Challenges
Table 17. Trigeminal Neuralgia Therapeutics Market Restraints
Table 18. Global Trigeminal Neuralgia Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Trigeminal Neuralgia Therapeutics Market Share by Players (2016-2021)
Table 20. Global Top Trigeminal Neuralgia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Trigeminal Neuralgia Therapeutics as of 2020)
Table 21. Ranking of Global Top Trigeminal Neuralgia Therapeutics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Trigeminal Neuralgia Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Trigeminal Neuralgia Therapeutics Product Solution and Service
Table 25. Date of Enter into Trigeminal Neuralgia Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Trigeminal Neuralgia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Trigeminal Neuralgia Therapeutics Revenue Market Share by Type (2016-2021)
Table 29. Global Trigeminal Neuralgia Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Trigeminal Neuralgia Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Trigeminal Neuralgia Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Trigeminal Neuralgia Therapeutics Revenue Market Share by Application (2016-2021)
Table 33. Global Trigeminal Neuralgia Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Trigeminal Neuralgia Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Trigeminal Neuralgia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Trigeminal Neuralgia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Trigeminal Neuralgia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Trigeminal Neuralgia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Trigeminal Neuralgia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Trigeminal Neuralgia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Trigeminal Neuralgia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Trigeminal Neuralgia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Trigeminal Neuralgia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Trigeminal Neuralgia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Trigeminal Neuralgia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Trigeminal Neuralgia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Trigeminal Neuralgia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Trigeminal Neuralgia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Trigeminal Neuralgia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Trigeminal Neuralgia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Trigeminal Neuralgia Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Trigeminal Neuralgia Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Trigeminal Neuralgia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Trigeminal Neuralgia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Trigeminal Neuralgia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Trigeminal Neuralgia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Trigeminal Neuralgia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Trigeminal Neuralgia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Trigeminal Neuralgia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Trigeminal Neuralgia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Trigeminal Neuralgia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Trigeminal Neuralgia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Trigeminal Neuralgia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Trigeminal Neuralgia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 65. Allergan, Inc. Company Details
Table 66. Allergan, Inc. Business Overview
Table 67. Allergan, Inc. Trigeminal Neuralgia Therapeutics Product
Table 68. Allergan, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2016-2021) & (US$ Million)
Table 69. Allergan, Inc. Recent Development
Table 70. Biogen, Inc. Company Details
Table 71. Biogen, Inc. Business Overview
Table 72. Biogen, Inc. Trigeminal Neuralgia Therapeutics Product
Table 73. Biogen, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2016-2021) & (US$ Million)
Table 74. Biogen, Inc. Recent Development
Table 75. Kineta, Inc. Company Details
Table 76. Kineta, Inc. Business Overview
Table 77. Kineta, Inc. Trigeminal Neuralgia Therapeutics Product
Table 78. Kineta, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2016-2021) & (US$ Million)
Table 79. Kineta, Inc. Recent Development
Table 80. Merz Pharma GmbH & Co. KgaA Company Details
Table 81. Merz Pharma GmbH & Co. KgaA Business Overview
Table 82. Merz Pharma GmbH & Co. KgaA Trigeminal Neuralgia Therapeutics Product
Table 83. Merz Pharma GmbH & Co. KgaA Revenue in Trigeminal Neuralgia Therapeutics Business (2016-2021) & (US$ Million)
Table 84. Merz Pharma GmbH & Co. KgaA Recent Development
Table 85. Trigemina, Inc. Company Details
Table 86. Trigemina, Inc. Business Overview
Table 87. Trigemina, Inc. Trigeminal Neuralgia Therapeutics Product
Table 88. Trigemina, Inc. Revenue in Trigeminal Neuralgia Therapeutics Business (2016-2021) & (US$ Million)
Table 89. Trigemina, Inc. Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Trigeminal Neuralgia Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. NeuroRelease TN Features
Figure 3. Onabotulinumtoxin A Features
Figure 4. Oxytocin Features
Figure 5. Raxatrigine Hydrochloride Features
Figure 6. U-2902 Features
Figure 7. Others Features
Figure 8. Global Trigeminal Neuralgia Therapeutics Market Share by Application: 2020 VS 2027
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Trigeminal Neuralgia Therapeutics Report Years Considered
Figure 13. Global Trigeminal Neuralgia Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Trigeminal Neuralgia Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Trigeminal Neuralgia Therapeutics Market Share by Regions: 2020 VS 2027
Figure 16. Global Trigeminal Neuralgia Therapeutics Market Share by Regions (2022-2027)
Figure 17. Global Trigeminal Neuralgia Therapeutics Market Share by Players in 2020
Figure 18. Global Top Trigeminal Neuralgia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Trigeminal Neuralgia Therapeutics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Trigeminal Neuralgia Therapeutics Revenue in 2020
Figure 20. Global Trigeminal Neuralgia Therapeutics Revenue Market Share by Type (2016-2021)
Figure 21. Global Trigeminal Neuralgia Therapeutics Revenue Market Share by Type (2022-2027)
Figure 22. North America Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Trigeminal Neuralgia Therapeutics Market Share by Type (2016-2027)
Figure 24. North America Trigeminal Neuralgia Therapeutics Market Share by Application (2016-2027)
Figure 25. North America Trigeminal Neuralgia Therapeutics Market Share by Country (2016-2027)
Figure 26. United States Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Trigeminal Neuralgia Therapeutics Market Share by Type (2016-2027)
Figure 30. Europe Trigeminal Neuralgia Therapeutics Market Share by Application (2016-2027)
Figure 31. Europe Trigeminal Neuralgia Therapeutics Market Share by Country (2016-2027)
Figure 32. Germany Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Trigeminal Neuralgia Therapeutics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Trigeminal Neuralgia Therapeutics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Trigeminal Neuralgia Therapeutics Market Share by Region (2016-2027)
Figure 42. China Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Trigeminal Neuralgia Therapeutics Market Share by Type (2016-2027)
Figure 50. Latin America Trigeminal Neuralgia Therapeutics Market Share by Application (2016-2027)
Figure 51. Latin America Trigeminal Neuralgia Therapeutics Market Share by Country (2016-2027)
Figure 52. Mexico Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Trigeminal Neuralgia Therapeutics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Trigeminal Neuralgia Therapeutics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Trigeminal Neuralgia Therapeutics Market Share by Country (2016-2027)
Figure 58. Turkey Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Trigeminal Neuralgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Allergan, Inc. Revenue Growth Rate in Trigeminal Neuralgia Therapeutics Business (2016-2021)
Figure 62. Biogen, Inc. Revenue Growth Rate in Trigeminal Neuralgia Therapeutics Business (2016-2021)
Figure 63. Kineta, Inc. Revenue Growth Rate in Trigeminal Neuralgia Therapeutics Business (2016-2021)
Figure 64. Merz Pharma GmbH & Co. KgaA Revenue Growth Rate in Trigeminal Neuralgia Therapeutics Business (2016-2021)
Figure 65. Trigemina, Inc. Revenue Growth Rate in Trigeminal Neuralgia Therapeutics Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed